If successful then Nasdaq listing and increased liquidity will follow. The stuffed the supply chain pretty good so q-3 should show a nice revenue increase. Long term the sizzle is in the lantbiotics and dpolt.
wrong its in SMART, a drug that can save the US 50 BILLION dollars per year in health care costs...every year, for the next 20 years
If SMaRT could save America $20 billion/year, how much could it save China, India, South America etc? Even if it's never approved here, it could be a world wide block buster.